IFM Investors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$799K Buy
40,947
+492
+1% +$9.76K 0.01% 573
2026
Q1
$778K Buy
40,455
+2,128
+6% +$41.9K 0.01% 578
2025
Q4
$726K Hold
38,327
0.01% 560
2025
Q3
$722K Buy
38,327
+195
+0.5% +$3.64K 0.01% 556
2025
Q2
$703K Sell
38,132
-9,371
-20% -$166K 0.01% 555
2025
Q1
$830K Sell
47,503
-6,947
-13% -$117K 0.01% 580
2024
Q4
$943K Buy
54,450
+1,064
+2% +$19.4K 0.01% 592
2024
Q3
$994K Sell
53,386
-17
-0% -$287 0.01% 597
2024
Q2
$822K Buy
+53,403
New +$763K 0.01% 601

Other funds holding SBRA

IFM Investors's SBRA Position: Q2 2026 in Review

IFM Investors increased its Sabra Healthcare REIT (SBRA) stake by 1.2% in Q2 2026, buying an estimated $9.76K and bringing the position to 40,947 shares worth $799K. The position accounts for 0.01% of the portfolio, ranked #573.

IFM Investors first reported a position in SBRA in Q2 2024 and has held it in 9 quarters since. The position peaked at $994K in Q3 2024. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • IFM Investors held 40,947 shares of Sabra Healthcare REIT worth $799K as of Q2 2026.
  • IFM Investors bought 492 Sabra Healthcare REIT shares in Q2 2026, an estimated $9.76K.
  • Sabra Healthcare REIT made up 0.01% of IFM Investors's portfolio in Q2 2026, its #573 holding.
  • IFM Investors first reported a position in Sabra Healthcare REIT in Q2 2024 and has held it in 9 quarters since.
  • IFM Investors's Sabra Healthcare REIT position peaked at $994K in Q3 2024.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.